Bakuchiol Matched Retinol on Wrinkles, Beat It on Pigmentation
Put retinol and bakuchiol side by side under the same clinical conditions for 12 weeks, and the result was closer than expected. Both significantly reduced wrinkle surface area and hyperpigmentation with no statistical difference between groups. Look at the numbers more carefully, though, and the pigmentation reduction was larger on the bakuchiol side, while scaling and stinging appeared only in the retinol group at statistically significant rates. That is why a 2019 randomized double-blind trial published in the British Journal of Dermatology keeps getting cited years after publication.
What Bakuchiol Actually Is
Bakuchiol is a compound extracted from the seeds of Psoralea corylifolia, a leguminous plant known in traditional East Asian medicine as babchi or bakuchi. The seeds have been used for centuries in Ayurvedic and Chinese herbal medicine, with historical records for skin conditions including psoriasis and vitiligo.
Structurally, bakuchiol has nothing in common with retinol. Retinol is a vitamin A derivative; bakuchiol is a meroterpene phenol. What they share is functional: bakuchiol binds to retinol receptors (RAR/RXR) in a similar fashion and activates intracellular signaling pathways involved in collagen synthesis. Different structure, same destination, which is why researchers began asking whether one could stand in for the other.
Retinol’s Two Liabilities
Retinol has held its place as the gold standard for photoaging care because the evidence is deep. Decades of clinical data show it accelerates epidermal cell turnover and stimulates dermal collagen synthesis with measurable results.
The liabilities come in two forms. The first is irritation. The so-called retinol reaction, characterized by flaking, stinging, and transient redness, is a well-documented consequence of starting or increasing retinol use. People with a compromised skin barrier experience it more intensely. The second is the pregnancy and breastfeeding contraindication. High-dose vitamin A derivatives are associated with fetal developmental risks, leading most medical guidelines to advise against any retinoid use during pregnancy and breastfeeding. Even though topical absorption is low, the recommendation across clinical guidelines is to avoid retinoids entirely during this period.
The Numbers from 12 Weeks
The BJD study enrolled 44 participants divided into two groups. The bakuchiol group applied a 0.5% cream twice daily. The retinol group applied a 0.5% cream once daily. High-resolution facial photographs were taken at weeks 0, 4, 8, and 12, with a blinded dermatologist grading pigmentation and erythema at each visit.
Wrinkle surface area decreased significantly in both groups, with no statistically significant difference between them. Hyperpigmentation also declined in both groups, but the reduction was greater in the bakuchiol arm. On the tolerability side, the difference was clear. Facial scaling and stinging occurred at statistically significantly higher rates in the retinol group. The bakuchiol group reported those symptoms at lower frequency.
If retinol used once daily still triggers these reactions, looking for an ingredient that delivers equivalent results with fewer side effects is a reasonable step to take.
What Equal Procollagen Levels Mean
Both groups showed a comparable rise in type I procollagen, the collagen precursor synthesized in the dermis, in the range of 23 to 26 percent. Procollagen is a structural marker, not just a skin-feel proxy. This tells you that both compounds are prompting actual dermal remodeling, not a surface-level change.
The significance here is that the two ingredients reach this outcome through different mechanisms. Retinol acts directly on nuclear receptors via intracellular retinol-binding proteins. Bakuchiol gets to a similar endpoint through a structurally distinct pathway. That difference is what prompts the hypothesis that the two ingredients could complement each other when combined. The clinical evidence for combination use is still limited.
Choosing During Pregnancy or Breastfeeding
The standard recommendation is to discontinue all retinoids from the point of pregnancy planning through the end of breastfeeding. For anyone trying to maintain a photoaging routine during that period, a gap opens up.
Bakuchiol has not been officially certified as safe for use during pregnancy or breastfeeding. What it lacks is the structural basis for the retinoid contraindication: it contains no vitamin A backbone and has not produced retinoid-type developmental toxicity in animal studies to date. This is why it is consistently mentioned as the closest available alternative for that specific window. As with any skincare ingredient during pregnancy, confirmation from an obstetrician or dermatologist is essential before starting use.
Reading the Concentration Label
The clinical evidence in the BJD trial used 0.5% bakuchiol. Products on the market range from 0.5% to 1%. There is no clinical data establishing that 1% outperforms 0.5%, and higher concentrations carry greater potential for irritation. If you are new to bakuchiol, 0.5% is the starting point most aligned with existing research. Look for products that clearly state the percentage on the label.
If you are considering using bakuchiol alongside retinol, the different mechanisms make co-use theoretically plausible. In practice, the risk of layered irritation is real. Establishing tolerance for each separately first, then adjusting timing or application frequency, is the more controlled approach.
Who Gets the Most From Bakuchiol
Three situations where bakuchiol holds a practical advantage over retinol.
Sensitive skin. If retinol consistently triggers visible irritation, an ingredient that shows equivalent efficacy in clinical testing while causing fewer side effects is worth considering.
Early-stage photoaging. For those in their late twenties or early thirties starting a preventive anti-aging routine, bakuchiol offers a way to begin building the habit without navigating the adaptation period that retinol requires.
Pregnancy planning or breastfeeding. During the window when retinoids are contraindicated, bakuchiol is currently the most frequently cited alternative for maintaining photoaging care. Specialist sign-off before use remains necessary.
On the other side, retinol’s deeper body of evidence, particularly for moderate to severe photoaging, acne scarring, and conditions requiring prescription-strength retinoids, keeps it the more thoroughly validated option in those contexts. Bakuchiol is not a replacement for every situation retinol covers. It is a solution for specific situations where retinol’s drawbacks outweigh its advantages.
Q. Can I use bakuchiol and retinol together?
Because the two ingredients work through different pathways, researchers have suggested they could theoretically be used together. In practice, combining them raises the risk of irritation. It’s safer to confirm tolerance for each one individually first, then adjust frequency or layering order carefully. Consult a dermatologist before combining.
Q. Can I fully switch from retinol to bakuchiol and expect the same results?
The BJD trial showed statistically equivalent wrinkle reduction at 12 weeks. That said, retinol carries decades of long-term evidence that bakuchiol hasn’t yet accumulated. If retinol causes significant irritation or you’re pregnant or breastfeeding, bakuchiol is a practical alternative. For advanced photoaging, a dermatologist consultation is the better first step.
Q. Does the concentration on the label matter, 0.5% vs 1%?
The clinical evidence is based on 0.5%. There is less data on 1%, and higher concentrations carry a higher potential for irritation. If you’re starting out, 0.5% is the concentration closest to the clinical data. Look for products that explicitly list ‘0.5% bakuchiol’ on the label.